These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9065257)

  • 1. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
    Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
    Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling acute tolerance to the EEG effect of two benzodiazepines.
    Ihmsen H; Albrecht S; Hering W; Schüttler J; Schwilden H
    Br J Clin Pharmacol; 2004 Feb; 57(2):153-61. PubMed ID: 14748814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects.
    Dingemanse J; Häussler J; Hering W; Ihmsen H; Albrecht S; Zell M; Schwilden H; Schüttler J
    Br J Anaesth; 1997 Nov; 79(5):567-74. PubMed ID: 9422892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures.
    Tang J; Wang B; White PF; Gold M; Gold J
    Anesth Analg; 1999 Oct; 89(4):893-8. PubMed ID: 10512261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
    Klotz U; Ziegler G; Ludwig L; Reimann IW
    J Clin Pharmacol; 1985 Sep; 25(6):400-6. PubMed ID: 2865275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
    Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
    Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
    Mandema JW; Kuck MT; Danhof M
    Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration-effect relationship, hemodynamics and respiration after infusion of the steroid anesthetic eltanolone in healthy subjects].
    Hering W; Ihmsen H; Uhrlau C; Schüttler J
    Anaesthesist; 1996 Dec; 45(12):1142-50. PubMed ID: 9065247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
    Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
    Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
    Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
    Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
    Berg AK; Myrvik MJ; Van Ess PJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.
    Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ
    Neuropharmacology; 1996; 35(9-10):1483-91. PubMed ID: 9014164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
    Gath I; Weidenfeld J; Collins GI; Hadad H
    Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.